A Phase 2 open-label trial of ATI-50002 Topical for the treatment of Alopecia Areata (AA).
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2017
At a glance
- Drugs ATI 50002 (Primary)
- Indications Alopecia areata
- Focus Therapeutic Use
- 07 Nov 2017 Status changed from planning to recruiting, according to an Aclaris Therapeutics media release.
- 07 Nov 2017 According to an Aclaris Therapeutics media release, data is expected to be available in the first half of 2018.
- 20 Mar 2017 New trial record